Application Nr Approved Date Route Status External Links
NDA022556 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Karbinal Er Extended-Release Oral Suspension Is An H 1 Receptor Antagonist Indicated For The Symptomatic Treatment Of: Seasonal And Perennial Allergic Rhinitis Vasomotor Rhinitis Allergic Conjunctivitis Due To Inhalant Allergens And Foods Mild, Uncomplicated Allergic Skin Manifestations Of Urticaria And Angioedema Dermatographism As Therapy For Anaphylactic Reactions Adjunctive To Epinephrine And Other Standard Measures After The Acute Manifestations Have Been Controlled Amelioration Of The Severity Of Allergic Reactions To Blood Or Plasma Karbinal Er (Carbinoxamine Maleate) Extended-Release Oral Suspension Is An H 1 Receptor Antagonist Indicated For The Symptomatic Treatment Of: Seasonal And Perennial Allergic Rhinitis ( 1 ) Vasomotor Rhinitis ( 1 ) Allergic Conjunctivitis Due To Inhalant Allergens And Foods ( 1 ) Mild, Uncomplicated Allergic Skin Manifestations Of Urticaria And Angioedema ( 1 ) Dermatographism ( 1 ) As Therapy For Anaphylactic Reactions Adjunctive To Epinephrine And Other Standard Measures After The Acute Manifestations Have Been Controlled ( 1 ) Amelioration Of The Severity Of Allergic Reactions To Blood Or Plasma ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Carbinoxamine Maleate CARBINOXAMINE MALEATE ZINC12358683

Comments